TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) is now available.
Sinco Pharmaceuticals Holdings Ltd. has released key findings from an internal control review conducted by external consultants. The review identified a breach in corporate governance related to an interest-free loan provided to a connected person, which violated the Listing Rules. The consultants recommended improvements, including designating personnel to manage compliance with transaction reporting requirements and maintaining proper documentation. The company has accepted these recommendations to enhance its governance practices.
The most recent analyst rating on (HK:6833) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Sinco Pharmaceuticals Holdings Ltd. stock, see the HK:6833 Stock Forecast page.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company is involved in the development and distribution of pharmaceutical products, with a focus on maintaining compliance with industry regulations and standards.
Average Trading Volume: 251,642
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$386.2M
For a thorough assessment of 6833 stock, go to TipRanks’ Stock Analysis page.